Physostigmine and atropine potentiate and inhibit neuronal alpha 4 beta 4 nicotinic receptors.
Zwart
R
R
Research Institute of Toxicology, Utrecht University, The Netherlands.
Van Kleef
R G
RG
Vijverberg
H P
HP
D000109:Acetylcholine / Q000494:pharmacology; D000818:Animals; D001285:Atropine / Q000494:pharmacology*; D018679:Cholinergic Agonists / Q000494:pharmacology; D004791:Enzyme Inhibitors / Q000494:pharmacology; D006624:Hippocampus / Q000378:metabolism; D009474:Neurons / Q000187:drug effects* / Q000378:metabolism; D009865:Oocytes / Q000378:metabolism; D018408:Patch-Clamp Techniques; D010830:Physostigmine / Q000494:pharmacology*; D011978:Receptors, Nicotinic / Q000187:drug effects*; D014981:Xenopus
D018679:Cholinergic Agonists; D004791:Enzyme Inhibitors; D011978:Receptors, Nicotinic; D001285:Atropine; D010830:Physostigmine; D000109:Acetylcholine